Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1 for 1₹76,670Accepted-Finance | ₹76,670 | L1 for 1 | Accepted-Finance Being L1 for 01 item. Pl refer attached comparative statement |
| 2 | L1 for 1₹1.1 LAccepted-Finance | ₹1.1 L | L1 for 1 | Accepted-Finance Being L1 for 01 item. Pl refer attached comparative statement |
| 3 | L1 for 1₹9.9 LAccepted-Finance | ₹9.9 L | L1 for 1 | Accepted-Finance Being L1 for 01 item. Pl refer attached comparative statement |
| 4 | L1 for 1₹11.8 LAccepted-Finance | ₹11.8 L | L1 for 1 | Accepted-Finance Being L1 for 01 item. Pl refer attached comparative statement |
| 5 | L1 for 1₹14.8 LAccepted-Finance | ₹14.8 L | L1 for 1 | Accepted-Finance Being L1 for 01 item. Pl refer attached comparative statement |
| Sl No | Description | Qty | Unit | THERDOSE PHARMA PVT LTD L1 | AstraZeneca Pharma India Limited L7 | Novartis Health Care Private Limited L8 | AbbVie Healthcare India Private Limited L6 | NATCO PHARMA LIMITED L5 | Getwell Pharma India Private Limited L3 | United Biotech (P) Ltd L4 | M/s Adley Formulation Private Limited L2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | ACALABRUTINIB CAP 100MG | 1 | 1 No | - | - | - | - | 170 ₹17,85,000 | - | - | 118 ₹12,39,000 Lowest |
| 2.00 | ACTINOMYCIN D INJ, 0.5mg/3ml | 1 | Vial | - | - | - | - | - | - | - | - |
| 3.00 | BCG FOR IMMUNOTHERAPY IP 40MG (BACILLUS CALMETTE GUERIN STRAIN 40MG/ML) | 1 | Vial | - | - | - | - | - | - | - | - |
| 4.00 | BOSUTINIB TAB 400MG | 1 | 1 No | - | - | - | - | - | - | - | - |
| 5.00 | CABOZANTINIB TAB 40MG | 1 | 1 No | - | - | - | - | 76.67 ₹80,500 Lowest | - | - | - |
| 6.00 | CYCLOPHOSPHAMIDE TAB IP, 50mg | 1 | 1 No | - | - | - | - | - | - | - | - |
| 7.00 | FLUDARABINE TAB, 10 mg | 1 | 1 No | - | - | - | - | - | - | 1,100 ₹1,15,500 Lowest | - |
| 8.00 | FLUROURACIL INJ IP, 250mg | 1 | Amp/Vial | - | - | - | - | - | - | - | - |
| 9.00 | IDARUBICIN INJ, 5 mg | 1 | Vial | - | - | - | - | - | - | 6,742 ₹10,61,865 Lowest | - |
| 10.00 | MELPHALAN TAB, 5mg | 1 | 1 No | - | - | - | - | - | - | - | - |
Tender Value
Refer Docs
EMD Value
₹10,000
Closing Date
5 Jun 2026, 5:00 pmClosed
Director
Regional Cancer Centre, Medical College Campus, Medical College PO, Trivandrum, Kerala 695011
Supply of 41 Anti Cancer (Generic / Innovator on demand) Drugs for the use in Regional Cancer Centre (RCC) from the original manufacturers and Direct Importers on rate contract basis
2026_RCC_849583_1
06/RCC/2026-27/E9983/P2
Open Tender
Medicines
Supply
45 days
Regional Cancer Centre
Please refer Tender documents.
13 documents required · 13 mandatory
₹10,000
₹10,000
16 Sept 2026
7 May 2026
8 Jun 2026
7 May 2026
5 Jun 2026
7 May 2026
7 May 2026 - 5 Jun 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount | HSN/SAC |
|---|---|---|---|---|---|---|
| 1 | ACALABRUTINIB CAP 100MG | 1 | 1 No | - | - | 10000 |
| 2 | ACTINOMYCIN D INJ, 0.5mg/3ml | 1 | Vial | - | - | 1200 |
| 3 | BCG FOR IMMUNOTHERAPY IP 40MG (BACILLUS CALMETTE GUERIN STRAIN 40MG/ML) | 1 | Vial | - | - | 600 |
| 4 | BOSUTINIB TAB 400MG | 1 | 1 No | - | - | 1000 |
| 5 | CABOZANTINIB TAB 40MG | 1 | 1 No | - | - | 1000 |
| 6 | CYCLOPHOSPHAMIDE TAB IP, 50mg | 1 | 1 No | - | - | 13000 |
| 7 | FLUDARABINE TAB, 10 mg | 1 | 1 No | - | - | 100 |
| 8 | FLUROURACIL INJ IP, 250mg | 1 | Amp/Vial | - | - | 6000 |
| 9 | IDARUBICIN INJ, 5 mg | 1 | Vial | - | - | 150 |
| 10 | MELPHALAN TAB, 5mg | 1 | 1 No | - | - | 2200 |
stage.html
html • 0.07 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Tendernotice_1.pdf
PDF • 0.61 MB
Comp_ACD_41.xls
Tender Documents • 0.25 MB
BOQ_1435594.xls
BOQ • 0.37 MB
Date_Extension_ACD.pdf
PDF • 0.20 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .